ENTITY

Physiomics (PYC LN)

34
Analysis
Industrials • United Kingdom
Physiomics is a data-driven consultancy that provides Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming, and Bioinformatics solutions to biopharmaceutical companies and research institutes. The company utilizes its proprietary Virtual Tumour technology platform to optimize the design of cancer clinical trials and predict the effects of treatments. Physiomics was founded in 2001 and is headquartered in Abingdon, United Kingdom.
more
•24 Mar 2026 21:04•Issuer-paid

Hybridan Small Cap Feast: 17 March 2026

Abingdon Health 8.25p £20.71m (ABDX.L) The developer, manufacturer and regulatory services provider for rapid diagnostic tests and medtech reports...

Logo
Hybridan
142 Views
Share
•18 Mar 2026 10:37•Issuer-paid

Hybridan Small Cap Feast: 10 March 2026

The Asset comprises a 3.5 megavolt-ampere live grid connection with an active transformer and associated electrical infrastructure, providing...

Logo
Hybridan
136 Views
Share
bullish•Altona Mining
•24 Feb 2026 10:03•Issuer-paid

Hybridan Small Cap Feast: 16 February 2026

The next test work phases will assess the most appropriate separation techniques for concentrating the key critical minerals.

Logo
Hybridan
122 Views
Share
•04 Feb 2026 19:02•Issuer-paid

Tortilla Mexican Grill PLC - Hybridan Small Cap Feast: 28 January 2026

The well was put on production at a heavily restricted rate, 21/128 choke and 30 Hz pump frequency, of around 230 BOPD gross (115 BOPD net).

Logo
Hybridan
153 Views
Share
bullish•Van Elle
•22 Dec 2025 19:02•Issuer-paid

Van Elle Holdings PLC - Friday Take Away: 15 December 2025

The Company bridges traditional finance and digital assets through a relationship-led fintech platform designed for institutional and professional...

Logo
Hybridan
328 Views
Share
x